Peter Bloch
Chief Executive Officer at BresoTEC and former Chairman and CEO at Bionik Laboratories.
Peter Bloch has more than 25 years of experience in leading healthcare and technology companies in the role of Chairman, CEO and previously CFO. This includes experience in both large Pharmaceutical (Sanofi -Aventis) and earlier stage Medical Device and Biotechnology companies (Bionik Laboratories, Tribute Pharmaceuticals and Intellivax).
Visit website: https://bresotec.com/bresotec-leadership/
See also: 
Bionik Laboratories
- Innovative medical device and robotics company developing exoskeleton for users with mobility impairments
Details last updated 28-Jan-2021
Peter Bloch News
Bionik starts production of ARKE GEN2
Bionik Laboratories - 15-Sep-2015
Lower-body exoskeleton has significantly smaller mechanics, improved battery density and power-to...
Read more...
